. 2015 Feb 10;81(5):1668–1678. doi: 10.1128/AEM.03582-14

TABLE 2.

Concentrations of OAs as a function of treatment after 24 h of in vitro fermentation of IVSF at 2.5 to 10 mg/ml, INU-5, or UFSF-5

Group	Concn^a (mmol/liter)
Group	Lactate	Propionate	Acetate	Butyrate	Valerate	Total
Baseline	0.41 ± 0.04^D	0.89 ± 0.02^E	2.53 ± 0.05^E	0.11 ± 0.02^B	0 ± 0^A	3.95 ± 0.09^F
Control	0.84 ± 0.09^D	5.87 ± 0.18^D	19.73 ± 3.17^D	0.96 ± 0.50^AB	0.29 ± 0.25^A	27.69 ± 4.15^E
IVSF-2.5	0.95 ± 0.07^CD	8.09 ± 1.69^C	22.25 ± 1.92^CD	3.65 ± 2.85^AB	1.40 ± 1.21^A	36.34 ± 1.51^D
IVSF-5	4.23 ± 0.69^BC	11.79 ± 0.63^A	28.36 ± 1.34^AB	1.86 ± 0.77^AB	0.50 ± 0.38^A	46.73 ± 1.22^B
IVSF-10	9.11 ± 3.85^A	10.77 ± 1.51^AB	30.50 ± 5.09^A	4.49 ± 4.29^A	1.52 ± 1.92^A	56.39 ± 3.68^A
INU-5	2.21 ± 0.86^CD	10.30 ± 0.63^AB	26.08 ± 1.86^BC	2.72 ± 1.49^AB	0.94 ± 0.69^A	42.25 ± 1.96^C
UFSF-5	6.19 ± 3.60^AB	9.56 ± 0.59^BC	23.57 ± 1.75^CD	3.22 ± 2.23^AB	0.95 ± 0.89^A	43.49 ± 1.84^BC

Values are for 10 piglets for each group. Nonsimilar letters denote significant differences (P < 0.05) for each column by one-way ANOVA after correction for multiple comparisons.